Stock JPH JERUSALEM PHARMACEUTICALS CO. LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Jerusalem Pharmaceuticals Co. Ltd.

Equities

JPH

PS2016112695

End-of-day quote Palestine Exchange
Other stock markets
 18:00:00 2024-04-24 EDT 		5-day change 1st Jan Change
3.81 USD 0.00% Intraday chart for Jerusalem Pharmaceuticals Co. Ltd. -0.52% +0.26%
2023 Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
Jerusalem Pharmaceuticals Co. Ltd. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2019
CI
Jerusalem Pharmaceuticals Co. Ltd. Approves Dividend for the Year 2018, Payable on 21 June 2019
CI
Jerusalem Pharmaceuticals Co. Ltd. Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2018
CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Consolidated Unaudited Earnings Results for the Year Ended December 31, 2018
CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Unaudited Earnings Results for the Nine Months Ended September 30, 2018
CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Consolidated Earnings Results for the First Half of 2018
CI
Jerusalem Pharmaceuticals Co. Ltd. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2018
CI
Jerusalem Pharmaceuticals Co. Ltd. Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2017
CI
Jerusalem Pharmaceuticals Co. Ltd. Announces Unaudited Earnings Results for the Full Year Ended December 31, 2017
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. JPH Stock
  4. News Jerusalem Pharmaceuticals Co. Ltd.